SCHEDULE 13G/A
Statement of Beneficial Ownership
Nurix Therapeutics, Inc. Filed Acc 0000902664-26-004581
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Vestal Point Capital, LP | 7,025,000 | 6.4% |
| Ryan Wilder | 7,025,000 | 6.4% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…